Ulrike Mann

1.6k total citations
26 papers, 1.2k citations indexed

About

Ulrike Mann is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ulrike Mann has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Ulrike Mann's work include Alzheimer's disease research and treatments (9 papers), Neurological diseases and metabolism (4 papers) and Prion Diseases and Protein Misfolding (4 papers). Ulrike Mann is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neurological diseases and metabolism (4 papers) and Prion Diseases and Protein Misfolding (4 papers). Ulrike Mann collaborates with scholars based in Germany, United States and Austria. Ulrike Mann's co-authors include Tomas Müller‐Thomsen, Sönke Arlt, Ulrike Beisiegel, Erich Mohr, Anatol Kontush, Roger M. Nitsch, Stefanie Ganzer, Ulrich Finckh, Giuliano Binetti and T N Chase and has published in prestigious journals such as Blood, Gastroenterology and Free Radical Biology and Medicine.

In The Last Decade

Ulrike Mann

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrike Mann Germany	16	481	417	254	190	157	26	1.2k
Gerard D. Schellenberg United States	18	841 1.7×	486 1.2×	438 1.7×	205 1.1×	184 1.2×	30	1.7k
Tomas Müller‐Thomsen Germany	14	435 0.9×	342 0.8×	252 1.0×	122 0.6×	135 0.9×	21	1.0k
Tejal Shah Australia	21	693 1.4×	452 1.1×	216 0.9×	154 0.8×	166 1.1×	52	1.6k
Eugene Hone Australia	18	760 1.6×	380 0.9×	277 1.1×	145 0.8×	100 0.6×	37	1.3k
Jolanta Dorszewska Poland	25	517 1.1×	710 1.7×	183 0.7×	254 1.3×	143 0.9×	94	1.9k
Miguel Baquero Spain	21	469 1.0×	425 1.0×	150 0.6×	156 0.8×	78 0.5×	50	1.3k
Masaru Minami Japan	19	279 0.6×	283 0.7×	87 0.3×	201 1.1×	167 1.1×	84	1.3k
Anita Garlind Sweden	17	782 1.6×	502 1.2×	123 0.5×	218 1.1×	263 1.7×	30	1.7k
Aaron Koenig United States	13	802 1.7×	431 1.0×	284 1.1×	317 1.7×	196 1.2×	26	1.8k
Mauricio O. Nava-Mesa Colombia	15	502 1.0×	316 0.8×	96 0.4×	302 1.6×	132 0.8×	27	1.3k

Countries citing papers authored by Ulrike Mann

Since Specialization

Citations

This map shows the geographic impact of Ulrike Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Mann more than expected).

Fields of papers citing papers by Ulrike Mann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Mann. The network helps show where Ulrike Mann may publish in the future.

Co-authorship network of co-authors of Ulrike Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Mann. A scholar is included among the top collaborators of Ulrike Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Mann. Ulrike Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doma, Eszter, Thorsten Klampfl, Michaela Prchal‐Murphy, et al.. (2024). Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood. 144(2). 156–170. 5 indexed citations

Schaller, Martin, Katharina J. Wenger, Christoph Mayer, et al.. (2023). Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium: Results from the REDUCE‐GAD trial. European Journal of Neurology. 30(8). 2393–2400. 6 indexed citations

Mann, Ulrike, et al.. (2018). Fake news? Biotin interference in thyroid immunoassays. Clinica Chimica Acta. 484. 320–322. 15 indexed citations

Kimeswenger, Susanne, Ulrike Mann, Christoph Höeller, Dagmar Foedinger, & Christian Jantschitsch. (2018). Vemurafenib impairs the repair of ultraviolet radiation-induced DNA damage. Melanoma Research. 29(2). 134–144. 10 indexed citations

Müller‐Thomsen, Tomas, et al.. (2004). Detecting depression in Alzheimer?s disease: evaluation of four different scales. Archives of Clinical Neuropsychology. 20(2). 271–276. 133 indexed citations

Grasbon-Frodl, E. M., Holger Lorenz, Ulrike Mann, et al.. (2004). Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathologica. 108(6). 476–484. 65 indexed citations

Mann, Ulrike, et al.. (2003). Internalization via plasmalemmal vesicles: a route for antidesmoplakin autoantibodies into cultured human keratinocytes. Experimental Dermatology. 12(5). 546–554. 2 indexed citations

Elbe‐Bürger, Adelheid, et al.. (2002). Overexpression of IL-4 Alters the Homeostasis in the Skin. Journal of Investigative Dermatology. 118(5). 767–778. 68 indexed citations

Müller‐Thomsen, Tomas, Sönke Arlt, Stefanie Ganzer, et al.. (2002). Depression in Alzheimer’s Disease Might Be Associated with Apolipoprotein E ε4 Allele Frequency in Women but Not in Men. Dementia and Geriatric Cognitive Disorders. 14(2). 59–63. 31 indexed citations

10.

Kontush, Anatol, et al.. (2001). Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer’s disease. Free Radical Biology and Medicine. 31(3). 345–354. 107 indexed citations

11.

Finckh, Ulrich, Tomas Müller‐Thomsen, Ulrike Mann, et al.. (2000). Reply to Croes et al.. The American Journal of Human Genetics. 67(4). 1035–1036.

12.

Schippling, Sven, Anatol Kontush, Sönke Arlt, et al.. (2000). Increased lipoprotein oxidation in alzheimer’s disease. Free Radical Biology and Medicine. 28(3). 351–360. 171 indexed citations

13.

Finckh, Ulrich, Tomas Müller‐Thomsen, Ulrike Mann, et al.. (2000). High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different Genes. The American Journal of Human Genetics. 66(1). 110–117. 148 indexed citations

14.

Finckh, Ulrich, Ulrike Mann, Christian Eggers, et al.. (2000). High Frequency of Mutations in Four Different Disease Genes in Early‐Onset Dementia. Annals of the New York Academy of Sciences. 920(1). 100–106. 23 indexed citations

15.

Nitsch, Roger M., Steven M. Greenberg, Ulrich Finckh, et al.. (1998). Genetic association of an ( 2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Human Molecular Genetics. 7(12). 1953–1956. 128 indexed citations

16.

Mann, Ulrike, Erich Mohr, M. Gearing, & T N Chase. (1992). Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.. Journal of Neurology Neurosurgery & Psychiatry. 55(10). 956–959. 66 indexed citations

17.

Mohr, Erich, Pim Brouwers, Jules J. Claus, et al.. (1991). Visuospatial cognition in Huntington's disease. Movement Disorders. 6(2). 127–132. 66 indexed citations

18.

Mann, Ulrike, et al.. (1989). Correlation of MRI findings and neuropsychological results in patients with multiple sclerosis. Psychiatry Research. 29(3). 293–294. 1 indexed citations

19.

Schlegel, Jerry F., Erich Mohr, J.A. Williams, et al.. (1989). Guanfacine Treatment of Alzheimerʼs Disease. Clinical Neuropharmacology. 12(2). 124–128. 23 indexed citations

20.

Mohr, Erich, J.U. Schlegel, Giovanni Fabbrini, et al.. (1989). Clonidine Treatment of Alzheimer's Disease. Archives of Neurology. 46(4). 376–378. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact